The Relationship Between Interleukin-4 Levels and Cardiovascular Events in Patients with Chronic Kidney Disease

Ling Gu1, Huogen Liu1, Xianhong Liu2

  • 1Department of Critical Care Medicine, Mindong Hospital of Fujian Medical University, Fuan, Fujian 355000, People's Republic of China.

Insights

Higher serum Interleukin-4 (IL-4) levels are linked to increased cardiovascular events in chronic kidney disease (CKD) patients. This finding may aid in early CV event prediction for individuals with CKD.

Area of Science:

  • Nephrology
  • Cardiology
  • Immunology

Background:

  • Cardiovascular diseases (CVDs) are the leading cause of mortality in chronic kidney disease (CKD) patients.
  • Interleukin-4 (IL-4), an inflammatory cytokine, has been minimally studied regarding its association with cardiovascular events in CKD.
  • This study addresses the gap by investigating the relationship between serum IL-4 levels and cardiovascular event risk in CKD.

Purpose of the Study:

  • To determine if serum IL-4 levels are associated with an increased risk of cardiovascular (CV) events in patients with CKD.
  • To explore the predictive value of IL-4 for early CV event detection in CKD.

Main Methods:

  • A cohort of 302 patients with stage 1-5 CKD were followed for a mean of 32 months.
  • Serum IL-4 levels were measured at baseline.
  • Multivariate Cox regression analysis was employed to assess the independent relationship between serum IL-4 and CV events.

Main Results:

  • The study included 302 patients (65.4 years average age, 69.9% male).
  • A total of 41 (13.6%) CV events occurred during follow-up.
  • Higher serum IL-4 levels (above mean of 126.2 pg/mL) were associated with a significantly increased rate of CV events (HR=1.650, P<0.001), particularly in CKD stages 3-5.
  • This association remained significant regardless of anti-inflammatory medication use.

Conclusions:

  • Elevated serum IL-4 levels are significantly associated with a higher risk of cardiovascular events in patients with CKD.
  • Serum IL-4 may serve as a valuable biomarker for predicting early cardiovascular events in the CKD population.
  • Stratified analysis indicated a stronger association in advanced CKD stages (3-5).
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
380
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
171
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
225
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
161
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
376
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
591